Albany, NY -- (SBWIRE) -- 06/24/2015 -- Available pharmacological treatment for conditions such as chronic pain, epilepsy, Parkinson's disease, and depression are not sufficient for all patients at all stages of treatment. More than 100 million people suffer from these conditions in the US alone. Though drug therapy, physiotherapy, and surgeries are effective treatment options, they are not suitable for all patients. For example, approximately 15-20% of epilepsy patients are drug-resistant and require alternate treatment method. Neurostimulation is a potential alternative for patients for whom the drug therapy or surgery is not effective.

Neurostimulation devices are implantable devices that help in the therapeutic activation of the nervous systems. These devices deliver electrical stimulation to the brain and nervous systems for the treatment of various types of neurological disorders such as pain, epilepsy, Parkinson's disease, depression, obsessive-compulsive disorder, dystonia, and tremors. These devices target specific areas of the brain or spinal cord by blocking the pain messages before they reach the brain.

Market analysts forecast the global neurostimulation devices market to grow at a CAGR of 5.37% over the period 2014-2019.

Visit To Read the Complete Report with Toc: http://www.marketresearchreports.biz/analysis/289832

Covered in this Report

The report covers the present scenario and the growth prospects of the global neurostimulation devices market for the period 2015-2019. Based on devises, the market can be segmented into the following: SCS systems, DBS systems, SNS systems, VNS systems, and others.

Recent report, Global Neurostimulation Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and APAC and EMEA; it also covers the global neurostimulation devices market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

Americas
APAC
EMEA

Key Vendors

Boston Scientific
Cyberonics
Medtronic
St. Jude Medical

Other Prominent Vendors

Aleva Neurotherapeutics
Atrotech
Autonomic Technologies
ElectroCore
Endostim
EnteroMedics
ImThera Medical
Inspire Medical Systems
Neuros Medical
NeuroMetrix
NeuroPace
NeuroSigma
Nevro
SPR Therapeutics
Synapse Biomedical

Download The sample Copy Of This Report: http://www.marketresearchreports.biz/sample/sample/289832

Market Driver

Rise in Prevalence of Neurological Disorders
For a full, detailed list, view our report

Market Challenge

Not First Line of Treatment Therapy
For a full, detailed list, view our report

Market Trend

Significant Increase in Product Development and Launches
For a full, detailed list, view our report

Key Questions Answered in this Report

What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

About MarketResearchReports.biz
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

To View The Top Related News: http://www.marketresearchreports.biz/articles

Contact:
Mr. Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: 518-618-1030
USA: Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/
Mail To: sales@marketresearchreports.biz